Company: MBIO
Filing Date: 2025-12-03
Form Type: DEF 14A
Source: 0001104659-25-118122
Chunk: 32

Company: MUSTANG BIO, INC.
Filing Date: 2025-12-03
Form: DEF 14A
Chunk 32
---
 information about our equity compensation plans as of December 31, 2024.

| ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 ​                                                          
 Plan Category                                              
 ​                                                          | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |                                    ​ 
 Equity Compensation Plan Information 
                                    ​ 
                                    ​ 
                                    ​ 
                                    ​ 
           Number of securities to be 
              issued upon exercise of 
                 outstanding options, 
                  warrants and rights 
                                  (a) | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ | ​                 
 ​                 
 ​                 
 Weighted-         
 average           
 exercise price of 
 outstanding       
 options, warrants 
 and rights        
 (b)               |        ​ 
        ​ 
        ​ | ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ 
 ​ |                     ​ 
                     ​ 
  Number of securities 
   remaining available 
   for future issuance 
          under equity 
    compensation plans 
 (excluding securities 
          reflected in 
           column (a)) 
                   (c) |
|:-----------------------------------------------------------|:--|-------------------------------------:|:--|:------------------|---------:|:--|----------------------:|
| Equity compensation plans approved by security holders     |   |                                1,521 | ​ | $                 | 4,297.50 |   |                 6,946 |
| Equity compensation plans not approved by security holders |   |                                    — | ​ |                   |        — |   |                     — |
| Total                                                      |   |                                1,521 | ​ | $                 | 4,297.50 |   |                 6,946 |

Our equity compensation plans consist of the EIP, and the Mustang Bio, Inc. 2019 Employee Stock Purchase Plan, which were each approved by our stockholders. We do not have any equity compensation plans or arrangements that have not been approved by our stockholders. DIRECTOR COMPENSATION Director Compensation Program In January 2016, the Board adopted a Non-Employee Directors Compensation Plan for our non-employee directors, which determines the cash and equity compensation payable to our non-employee directors. The Non-Employee Directors Compensation Plan provides for our non-employee directors to receive the following compensation: Cash Compensation:

| ● | $50,000 annual retainer; and |

| ● | $10,000 additional annual